Related Experiment Video
Updated: May 11, 2026
The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
Analysis of the application of MMP-9 inhibitor in skin melanoma: experimental study
1Prof. V. V. Ivanov Department of Pathological Physiology with the Course of Clinical Pathophysiology, Prof. V. F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Russia.
Abstract:
Experiment on C57Bl/6 mice with modeled skin melanoma showed that selective inhibition of matrix metalloproteinase-9 increased lifetime and reduced the number of PCNA(+) tumor cells and intensity of neoangiogenesis. Inhibition of matrix metalloproteinase-9 prevented tumor necrosis. The results suggest that matrix metalloproteinase-9 is involved not only in the regulation of extracellular matrix degradation, but also in the processes of cell proliferation and neoangiogenesis in skin melanoma. Therefore, this enzyme can be considered as a potential therapeutic target.
Insights
Selective inhibition of matrix metalloproteinase-9 (MMP-9) in mice with skin melanoma extended survival and reduced tumor cell proliferation and blood vessel growth. MMP-9 inhibition also prevented tumor necrosis, suggesting it is a viable therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinase-9 (MMP-9) is implicated in extracellular matrix degradation.
- Its role in melanoma progression, including cell proliferation and angiogenesis, requires further elucidation.
Purpose of the Study:
- To investigate the therapeutic potential of selective matrix metalloproteinase-9 inhibition in a murine model of skin melanoma.
Main Methods:
- C57Bl/6 mice with induced skin melanoma were treated with a selective MMP-9 inhibitor.
- Tumor growth, cell proliferation (PCNA staining), neoangiogenesis, and necrosis were assessed.
Main Results:
- Selective MMP-9 inhibition significantly increased mouse lifespan.
- A reduction in proliferating cell nuclear antigen (PCNA)-positive tumor cells and neoangiogenesis intensity was observed.
- Inhibition of MMP-9 prevented tumor necrosis.
Conclusions:
- Matrix metalloproteinase-9 plays a crucial role in skin melanoma progression beyond extracellular matrix remodeling.
- MMP-9 is involved in regulating tumor cell proliferation and neoangiogenesis.
- Targeting MMP-9 represents a promising therapeutic strategy for skin melanoma.
